Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Sustained Inflammatory Signalling through Stat1/Stat2/IRF9 Is Associated with Amoeboid Phenotype of Melanoma Cells

A. Gandalovičová, AM. Šůchová, V. Čermák, L. Merta, D. Rösel, J. Brábek,

. 2020 ; 12 (9) : . [pub] 20200828

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20021740

Grantová podpora
18-15684J Grantová Agentura České Republiky

The invasive behaviour of cancer cells underlies metastatic dissemination; however, due to the large plasticity of invasion modes, it is challenging to target. It is now widely accepted that various secreted cytokines modulate the tumour microenvironment and pro-inflammatory signalling can promote tumour progression. Here, we report that cells after mesenchymal-amoeboid transition show the increased expression of genes associated with the type I interferon response. Moreover, the sustained activation of type I interferon signalling in response to IFNβ mediated by the Stat1/Stat2/IRF9 complex enhances the round amoeboid phenotype in melanoma cells, whereas its downregulation by various approaches promotes the mesenchymal invasive phenotype. Overall, we demonstrate that interferon signalling is associated with the amoeboid phenotype of cancer cells and suggest a novel role of IFNβ in promoting cancer invasion plasticity, aside from its known role as a tumour suppressor.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20021740
003      
CZ-PrNML
005      
20201204092700.0
007      
ta
008      
201125s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers12092450 $2 doi
035    __
$a (PubMed)32872349
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Gandalovičová, Aneta $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
245    10
$a Sustained Inflammatory Signalling through Stat1/Stat2/IRF9 Is Associated with Amoeboid Phenotype of Melanoma Cells / $c A. Gandalovičová, AM. Šůchová, V. Čermák, L. Merta, D. Rösel, J. Brábek,
520    9_
$a The invasive behaviour of cancer cells underlies metastatic dissemination; however, due to the large plasticity of invasion modes, it is challenging to target. It is now widely accepted that various secreted cytokines modulate the tumour microenvironment and pro-inflammatory signalling can promote tumour progression. Here, we report that cells after mesenchymal-amoeboid transition show the increased expression of genes associated with the type I interferon response. Moreover, the sustained activation of type I interferon signalling in response to IFNβ mediated by the Stat1/Stat2/IRF9 complex enhances the round amoeboid phenotype in melanoma cells, whereas its downregulation by various approaches promotes the mesenchymal invasive phenotype. Overall, we demonstrate that interferon signalling is associated with the amoeboid phenotype of cancer cells and suggest a novel role of IFNβ in promoting cancer invasion plasticity, aside from its known role as a tumour suppressor.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šůchová, Anna-Marie $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
700    1_
$a Čermák, Vladimír $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
700    1_
$a Merta, Ladislav $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
700    1_
$a Rösel, Daniel $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
700    1_
$a Brábek, Jan $u Department of Cell Biology, Charles University, 12843 Prague, Czech Republic. Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), 25242 Vestec, Czech Republic.
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 12, č. 9 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32872349 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201204092658 $b ABA008
999    __
$a ind $b bmc $g 1591449 $s 1112412
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 12 $c 9 $e 20200828 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
GRA    __
$a 18-15684J $p Grantová Agentura České Republiky
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...